Quick Answer
VERTEX PHARMACEUTICALS INC / MA reported Total Assets of $25.64 billion for the year ending 2025.
- VERTEX PHARMACEUTICALS INC / MA showed an increase of +13.8% in Total Assets from 2024 to 2025.
- This data is from VERTEX PHARMACEUTICALS INC / MA's annual report (Form 10-K), filed with the SEC on February 13, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2010: $1.77 billion | Q2 2010: $1.65 billion | Q3 2010: $1.89 billion | Q1 2011: $1.54 billion | Q2 2011: $1.76 billion | Q3 2011: $2.09 billion | Q1 2012: $2.35 billion | Q2 2012: $2.60 billion | Q3 2012: $2.72 billion | Q1 2013: $2.39 billion | Q2 2013: $2.58 billion | Q3 2013: $2.58 billion | Q1 2014: $2.20 billion | Q2 2014: $2.12 billion | Q3 2014: $2.41 billion | Q1 2015: $2.17 billion | Q2 2015: $2.37 billion | Q3 2015: $2.43 billion | Q1 2016: $2.49 billion | Q2 2016: $2.55 billion | Q3 2016: $2.61 billion | Q1 2017: $2.95 billion | Q2 2017: $3.29 billion | Q3 2017: $3.20 billion | Q1 2018: $3.95 billion | Q2 2018: $4.34 billion | Q3 2018: $4.62 billion | Q1 2019: $6.54 billion | Q2 2019: $7.03 billion | Q3 2019: $7.51 billion | Q1 2020: $8.89 billion | Q2 2020: $10.22 billion | Q3 2020: $11.30 billion | Q1 2021: $12.12 billion | Q2 2021: $12.22 billion | Q3 2021: $12.62 billion | Q1 2022: $14.26 billion | Q2 2022: $15.58 billion | Q3 2022: $16.71 billion | Q1 2023: $18.97 billion | Q2 2023: $20.35 billion | Q3 2023: $21.73 billion | Q1 2024: $23.92 billion | Q2 2024: $20.13 billion | Q3 2024: $22.24 billion | Q1 2025: $22.88 billion | Q2 2025: $24.04 billion | Q3 2025: $24.86 billion.
- Over the full 17 years of available data (2009 to 2025), VERTEX PHARMACEUTICALS INC / MA's Total Assets has grown by 1,211.3%.
- Historical annual values: Fiscal year 2025: $25.64 billion | Fiscal year 2024: $22.53 billion | Fiscal year 2023: $22.73 billion | Fiscal year 2022: $18.15 billion | Fiscal year 2021: $13.43 billion | Fiscal year 2020: $11.75 billion | Fiscal year 2019: $8.32 billion | Fiscal year 2018: $6.25 billion | Fiscal year 2017: $3.55 billion | Fiscal year 2016: $2.90 billion | Fiscal year 2015: $2.50 billion | Fiscal year 2014: $2.33 billion | Fiscal year 2013: $2.32 billion | Fiscal year 2012: $2.76 billion | Fiscal year 2011: $2.20 billion | Fiscal year 2010: $1.73 billion | Fiscal year 2009: $1.96 billion.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: